A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months

por Carmona Martinez, Alfonso, Salamanca de la Cueva, Ignacio, Boutet, Philippe, Vanden Abeele, Carline, Smolenov, Igor, Devaster, Jeanne-Marie
Publicado 2014

Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistenc...

por Díez-Domingo, Javier, Baldó, José-María, Planelles-Catarino, Maria Victoria, Garcés-Sánchez, María, Ubeda, Isabel, Jubert–Rosich, Angels, Marès, Josep, Garcia-Corbeira, Pilar, Moris, Philippe, Teko, Maurice, Vanden Abeele, Carline, Gillard, Paul
Publicado 2015

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

por Leroux-Roels, Isabel, Davis, Matthew G, Steenackers, Katie, Essink, Brandon, Vandermeulen, Corinne, Fogarty, Charles, Andrews, Charles P, Kerwin, Edward, David, Marie-Pierre, Fissette, Laurence, Vanden Abeele, Carline, Collete, Delphine, de Heusch, Magali, Salaun, Bruno, De Schrevel, Nathalie, Koch, Juliane, Verheust, Céline, Dezutter, Nancy, Struyf, Frank, Mesaros, Narcisa, Tica, Jelena, Hulstrøm, Veronica
Publicado 2022